A carregar...

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.

Methoxymorpholinyl doxorubicin (MMDX) is a novel anti-cancer anthracycline that differs from doxorubicin in its mechanisms of action, pattern of resistance and metabolism. Whereas doxorubicin is primarily an inhibitor of topoisomerase II, MMDX inhibits both topoisomerases I and II, resulting in pred...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lau, D. H., Duran, G. E., Lewis, A. D., Sikic, B. I.
Formato: Artigo
Idioma:English
Publicado em: Nature Publishing Group 1994
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033319/
https://ncbi.nlm.nih.gov/pubmed/8018545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!